Skip to content

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05168605
Enrollment
100
Registered
2021-12-23
Start date
2022-07-27
Completion date
2026-12-31
Last updated
2026-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Type 2 Diabetes

Brief summary

The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.

Detailed description

The purpose of this study is to compare the health outcomes utilizing home medical visits to manage hypertension and type 2 diabetes as compared to standard of care clinic visits. This project has 3 overall objectives: 1. To test the efficacy of home medical visits by Family Medicine physicians specifically designed for patients with hypertension (HTN) and Type 2 Diabetes Mellitus (T2DM) 2. To compare primary outcome of the patients randomly selected for home visits to similar patients receiving usual care in the clinical setting 3. To understand the efficacy and impact of the home visit from the patient perspective Study participant will receive usual care from a resident doctor in home. There will be (2) home visits conducted over the course of this study that will include a comprehensive assessment of hypertension, type 2 diabetes, and social factors that may be impacting their health. Study participants will also be asked to complete several questionnaires related to their knowledge of chronic diseases, personal health management, and experience of the study home visits.

Interventions

Patients receiving home Visits

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

This study includes prospective intervention arm and historical control arm (data will be collected via retrospective chart review).

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients ages 18-60 * Spanish or English speaking * Diagnosis of HTN or BP \>140/90 in last 3 months (based on medical record) * Hemoglobin A1C\>8 in last 6 months (based on medical record) * Not pregnant

Exclusion criteria

* Current oral steroid use * History of solid organ transplant * Language other than English or Spanish

Design outcomes

Primary

MeasureTime frameDescription
Change in Blood pressureBaseline, 6 monthsChange in blood pressure will be measured at baseline, 6 months using an automated blood pressure machine. Blood pressure is measured as systolic blood pressure/diastolic blood pressure in millimeters of mercury

Countries

United States

Contacts

CONTACTSilvia Obregon, MSW
silvia.obregon@utsouthwestern.edu214-645-9532
PRINCIPAL_INVESTIGATORNora Gimpel, M.D.

University of Texas Southwestern Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026